Stay updated with breaking news from Christopher Rovaldi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results Lexington, Mass. - March 9, 2022 - Keros... | March 9, 2022
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 31, 2022, Keros Therapeutics,... | January 31, 2022
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer - read this article along with other careers information, tips and advice on BioSpace